Yale Medicine School Decade-Long Effort to Increase Diversity in Clinical Trials
July 08, 2022
July 08, 2022
NEW HAVEN, Connecticut, July 8 (TNSres) -- Yale School of Medicine issued the following news:
The participation of minority groups in clinical trials is an ongoing challenge that was underscored during the COVID-19 pandemic: Black individuals represented 21% of COVID-19 deaths, yet they comprised just 3% of major vaccine trial participants. Other minority groups were also underrepresented.
For over a decade, the Yale Center of Clinical Investigation (YCCI) has spearhead . . .
The participation of minority groups in clinical trials is an ongoing challenge that was underscored during the COVID-19 pandemic: Black individuals represented 21% of COVID-19 deaths, yet they comprised just 3% of major vaccine trial participants. Other minority groups were also underrepresented.
For over a decade, the Yale Center of Clinical Investigation (YCCI) has spearhead . . .